Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 2/20 | 0.36 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6523874 | 0.91 | TDP1 (0.38) | SMN1; SMN2LMNATSHRCTSKTDP1 | |
| SCHEMBL6523978 | 0.89 | ALDH1A1 (0.44) | SMN1; SMN2LMNAL3MBTL1TSHRCTSB | |
| SCHEMBL6515878 | 0.83 | ALDH1A1 (0.46) | SMN1; SMN2LMNAL3MBTL1TSHRALDH1A1 | |
| SCHEMBL6515864 | 0.79 | THRB (0.46) | L3MBTL1TSHRALDH1A1TDP1 | |
| SCHEMBL6520310 | 0.78 | THRB (0.35) | — | |
| SCHEMBL6519684 | 0.77 | L3MBTL1 (0.39) | LMNAL3MBTL1TSHRALDH1A1MAPK1 | |
| SCHEMBL6514764 | 0.76 | MAPT (0.36) | HTTLMNATSHRALDH1A1 | |
| SCHEMBL6514718 | 0.76 | HCAR2 (0.41) | TSHR | |
| SCHEMBL9358970 | 0.76 | TSHR (0.50) | SMN1; SMN2LMNAL3MBTL1TSHRALDH1A1 | |
| SCHEMBL6513722 | 0.75 | SMN1; SMN2 (0.43) | SMN1; SMN2HTTLMNAL3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | SMN1; SMN2 1768/4885HTT 3273/4885LMNA 2459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.